{
    "2018-02-27": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Eli Lilly Needs to Prove It Can Overcome Resistance Above $82",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Resistance",
                        "$82"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Lilly's Verzenio Wins FDA Nod for First Line Breast Cancer",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Verzenio",
                        "FDA",
                        "Breast Cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Lilly's Verzenio Wins FDA Nod for First Line Breast Cancer",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Verzenio",
                        "FDA",
                        "Breast Cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "Benzinga Pro's 5 Stocks To Watch Today",
                "features": {
                    "keywords": [
                        "Benzinga",
                        "Stocks",
                        "Watch"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}